Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(18%)
Results Posted
17%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
4
36%
Ph phase_2
2
18%
Ph phase_4
5
45%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 4Post-market surveillance
5(45.5%)
N/ANon-phased studies
4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 45 (45.5%)
N/A4 (36.4%)

Trials by Status

unknown218%
completed655%
recruiting218%
terminated19%

Recent Activity

2 active trials
Showing 5 of 11
recruitingnot_applicable

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

NCT06880198
unknownnot_applicable

Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.

NCT06128798
recruitingnot_applicable

Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer

NCT04469504
completedphase_2

Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation

NCT05101889
completednot_applicable

Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck Cancer

NCT01149642
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06880198Not Applicable

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

Recruiting
NCT06128798Not Applicable

Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.

Unknown
NCT04469504Not Applicable

Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer

Recruiting
NCT05101889Phase 2

Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation

Completed
NCT01149642Not Applicable

Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck Cancer

Completed
NCT01256047Phase 4

Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy

Completed
NCT01969110Phase 4

Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Unknown
NCT01256034Phase 4

Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Completed
NCT00151671Phase 2

Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer

Terminated
NCT00559520Phase 4

The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery

Completed
NCT00668876Phase 4

Effects of Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Completed

All 11 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11